This inventor holds 1 USPTO granted patent. Top assignee: Sagimet Biosciences Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: George Kemble: Inventor in Biotechnology
Introduction
George Kemble is an inventor based in Saratoga, California, whose patent work concerns potential therapeutic combinations for metabolic and liver disorders. He is associated with Sagimet Biosciences Inc.
Latest Patents
Kemble is named on 1 patent: “Combination Therapies of FASN Inhibitors with Thyroid Hormone Receptor Agonists.” The patent describes combinations of fatty acid synthesis modulators and thyroid hormone receptor agonists that may be used to treat disorders, including metabolic disorders and liver conditions such as nonalcoholic steatohepatitis, also known as metabolic dysfunction-associated steatohepatitis (NASH/MASH).
Career Highlights
The patent reflects work on therapeutic approaches that combine fatty acid synthesis modulation with thyroid hormone receptor activation. These approaches are described as potential treatments for metabolic and liver disorders.
Collaborations
Kemble’s listed coworkers include Anne-Marie O’Farrell and Wen-Wei Tsai. The patent’s subject matter reflects collaborative research in therapeutic development.
Conclusion
George Kemble’s recorded invention focuses on combining FASN inhibitors with thyroid hormone receptor agonists, highlighting his contribution to research into potential treatments for metabolic and liver disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile